However, despite the high incidence of these risk factors, sexual function and fertility seems to be normal in most patients. Taskinen, S. et al. Nat. Rev. Urol. 9, 699-706 (2012); published online 13 November 2012; doi:10.1038/nrurol.2012.196″
“Objective: To investigate the effect of anesthesia on the cognitive status damage and MMP-2 expression in rats. Methods: A total of 120 healthy rats were selected and randomly divided into the control group, CF3-CH(OCH2F)-CF3 (Sevoflurane) group and CF3-CH2-O-CHF-CF3 group (Sevoflurane) (n=40). After Compound C ic50 training for 3 d by the Morris water maze,
the control group were injected with fentanyl for analgesia, the CF3-CH(OCH2F)-CF3 group and the CF3-CH2-O-CHF-CB group were anesthesia with CF3-CH (OCH2F)-CF3 and CF3-CH2-O-CHF-CF3 on the basis of fentanyl, then rats in three groups underwent open surgery and suture conventional incision. Morris water maze was used to measure the rats’ cognitive ability in three groups on the 1st d, 3rd d, 5th d and 7th d, and the brain tissue MMP-2 expression was detected. Results: After 1 d/7 d of the surgery, Morris water maze performance and MMP-2 expression were
not significantly different among three groups (P>0.05); After 3 d/5 d of the surgery, compared with the control group, the Morris water maze test result was significantly worsened, MMP-2 expression levels were significantly increased (P<0.05); After 3 d/5 d of the surgery, JQ-EZ-05 molecular weight compared with the CF3-CH2-O-CHF-CF3 group, Morris water maze test result of CF3-CH(OCH2F)-CF3 group was significantly worsened, MMP-2 expression levels were significantly increased (P<0.05). Conclusions: Anesthesia can cause some injury on cognitive status, different anesthetic drugs may cause different injury, and the cognitive status injury is related to the MMP-2 expression.”
“BACKGROUND AND OBJECTIVE: To evaluate the clinical outcome and
complications of intravitreal injections of triamcinolone acetonide as adjuvant to reduce postoperative macular edema in patients undergoing pars plana vitrectomy for epiretinal membranes.\n\nPATIENTS AND METHODS: This retrospective comparative study LY2157299 molecular weight included 22 patients (22 eyes) who underwent pars plana vitrectomy with membrane peeling for the treatment of idiopathic epiretinal membrane. Fifteen eyes (15 patients) received an intravitreal injection of 4 mg (0.1 cc) of triamcinolone acetonide at the end of surgery, and no injection was performed for 7 eyes (7 patients). Main outcome measures were visual acuity and intraocular pressure. Minimum follow-up was 3 months.\n\nRESULTS: Twenty-two eyes of 22 patients were included in the study. The follow-up ranged from 3 to 12 months. Visual acuity improved in both groups at 3 months: logarithm of the minimum angle of resolution -0.26 +/- 0.19 in the triamcinolone acetonide group (P = .001) and -0.26 +/- 0.13 in the control group (P = .002).